Battle Pits Patent Rights Against Low-Cost Generic Drugs

January 30, 2007

The supply of low-cost generic versions of cancer and AIDS treatments for the developing world could be blocked if Novartis wins a legal challenge to India’s patent law, patients’ rights groups have contended. (New York Times)